Interés Humano

Agencia Europea aprueba tercera dosis de vacuna contra la covid-19 para mayores de 18 años

La EMA avala una dosis de refuerzo de la farmacéutica estadounidense Pfizer

(FILES) In this file photo taken on October 1, 2021, a vial of Pfizer COVID-19 booster vaccination sits on a table at a vaccination booster shot clinic in San Rafael, California. - The EU's drug watchdog on October 4, 2021 approved a third booster dose of the Pfizer/BioNTech Covid vaccine for people aged 18 and over amid concerns that protection dips after initial jabs. "Comirnaty booster doses may be considered for people aged 18 years and older, at least six months after the second dose," the European Medicines Agency said in a statement, referring to the brand name for the Pfizer vaccine. (Photo by JUSTIN SULLIVAN / GETTY IMAGES NORTH AMERICA / AFP)
(FILES) In this file photo taken on October 1, 2021, a vial of Pfizer COVID-19 booster vaccination sits on a table at a vaccination booster shot clinic in San Rafael, California. - The EU's drug watchdog on October 4, 2021 approved a third booster dose of the Pfizer/BioNTech Covid vaccine for people aged 18 and over amid concerns that protection dips after initial jabs. "Comirnaty booster doses may be considered for people aged 18 years and older, at least six months after the second dose," the European Medicines Agency said in a statement, referring to the brand name for the Pfizer vaccine. (Photo by JUSTIN SULLIVAN / GETTY IMAGES NORTH AMERICA / AFP) JUSTIN SULLIVAN
‌
‌

‌

‌
‌

‌

‌